Repare Therapeutics’ Post

View organization page for Repare Therapeutics, graphic

14,447 followers

2mo

CONFERENCE UPDATE: The abstract is available for Repare Therapeutics' presentation at ESMO GI from the Phase 1 MINOTAUR trial evaluating lunresertib in combination with FOLFIRI. Learn more here: https://lnkd.in/ebPvugmb #precisiononcology #syntheticlethality #clinicaltrials

3 Comments

Darren Nelson 🚀 (We're hiring)

Innovative Leadership in Life Sciences & Technology Talent Solutions: Founder & CEO of Recruits Lab & BioJobs Lab, Driving Organizational Success through Cutting-Edge Recruitment Strategies

2mo

Congratulations on sharing the abstract for your presentation at ESMO GI, Repare Therapeutics! The Phase 1 MINOTAUR trial's evaluation of lunresertib in combination with FOLFIRI sounds promising in advancing precision oncology. Wishing you great success as you continue to contribute to the field of synthetic lethality and clinical trials. Looking forward to learning more about your findings! 🌟 #PrecisionOncology #ClinicalResearch #ESMOGI

Darwin Ye

Penn Ph.D | Parker Institute for Cancer Immunotherapy

2mo

Looking forward to this!

1 Reaction

Gagan Kukreja

Associate Director, Medicinal Chemistry, SynVent IDD, Syngene

2mo

Really encouraging. Best Wishes for the journey ahead.

See more comments

To view or add a comment, sign in

More Relevant Posts

Marina Puchinskaya

Medical Oncologist, Researcher – Minsk City Clinical Oncologic Centre, ESO Ambassador
4mo
Report this post
With such brilliant panel of experts you just can't afford to miss this webinar! #ESMO #PrecisionOncology #biomarkers
ESMO - European Society for Medical Oncology

79,285 followers
4mo Edited

The last webinar in the #PrecisionOncology series presents ESMO’s new proposal for a classification of tissue-agnostic therapeutics. Secure your place and have your questions answered by international experts. 👉Register now with your ESMO account: 🔗https://ow.ly/G41o50R95Gk Claudia Cardone, Vivek Subbiah, Sewanti Limaye, Benedikt Westphalen, George Pentheroudakis
Like Comment
To view or add a comment, sign in
Kristi Campoe, PhD, RN, CMSRN, CPHQ, sMBA Kristi Campoe, PhD, RN, CMSRN, CPHQ, sMBA is an Influencer

FemTech Leader | Board Director | Medical Device Expert | Scientist | The BOLD Nurse Coach & Consultant | MEDSURG Nurse Advocate | Author
6mo
Report this post
It's not too late to attend this webinar today - Pharmacogenomics: Transforming Patient Care
Academy of Medical-Surgical Nurses (AMSN) & Medical-Surgical Nursing Certification Board (MSNCB)

2,866 followers
6mo

Our first webinar of the year is happening tomorrow! Join us from 2 p.m. - 3 p.m. CT as we cover "Pharmacogenomics: Transforming Patient Care". This is a can't-miss session that will explore all about the basics of pharmacogenomics, implications of testing, current uses of pharmacogenomic therapeutics, and more. Register now: https://hubs.la/Q02hTJj30
Like Comment
To view or add a comment, sign in
SeromYx Systems

564 followers
4mo
Report this post
Come join us on April 17th at 9am at the Colonnade Hotel in Boston, MA at the 4th Fc Mediated Function Summit and learn about how to incorporate our platform in order to develop safer more efficacious monoclonal therapeutics. #mAbtherapeutics #Fceffectorfuntion #Fcmediatedfunctionsummit
Like Comment
To view or add a comment, sign in
International Union Against Tuberculosis and Lung Disease (The Union)

20,483 followers
9mo
Report this post
🚀 Explore the Special Session: "SPS-04 TB therapeutics: Reflecting on the past and charting the way forward" at 15:00 CET in Room 242A. Join the discussion on groundbreaking approaches to TB treatment. Your engagement contributes to the ongoing quest for innovative therapeutics 🙌 #TB #Research #UnionConf2023
Like Comment
To view or add a comment, sign in
Halia Therapeutics, Inc.

1,917 followers
9mo Edited
Report this post
Today, Halia Therapeutics announced that David Bearss Ph.D., President and CEO of Halia, will be presenting and participating in a panel discussion at the 5th Inflammasome Therapeutics Summit. The Summit is taking place on November 28-30, in Boston, MA. To read the full release, visit: https://prn.to/49NjLTM #inflammasome #chronicinflammation #NLRP3 #therapeutics #halia #newsrelease #therapeuticssummit
Like Comment
To view or add a comment, sign in
Argenica Therapeutics

1,896 followers
11mo
Report this post
ARG-007 has reached a number of key clinical milestones, with Argenica currently preparing for Stage 2 clinical trials later this year. Here are just a few things that sets ARG-007 apart when it comes to stroke therapeutics. To learn more, download our most recent Investor Presentation: https://bit.ly/3EpPzPO #ASX #AGN #ARG007 #stroketheraputics #clinicaltrials
Like Comment
To view or add a comment, sign in
RegMedNet

1,746 followers
9mo
Report this post
CRISPR-based therapeutics: cultivating a seamless transition from discovery to delivery with Synthego Corporation's John Walker! Register for this upcoming webinar and uncover methods for resolving impurities in clinical-grade sgRNAs >>> https://bit.ly/46BgVPn
Like Comment
To view or add a comment, sign in
WuXi Chemistry

16,256 followers
5mo
Report this post
Day 1: Working on #oligonucleotide-based therapies? Connect with our WuXi TIDES team at the 9th OPT Congress in Boston from March 13-14. On March 13 at 12:45 pm EST, Yvonne Angell, Ph.D., our Executive Director and Head of TIDES discovery project management, will outline the technical challenges encountered in the discovery phase of oligonucleotide therapeutics. Through two case studies, we’ll detail our strategies for advancing programs from discovery to development, addressing technical obstacles and optimizing our approach. This presentation will offer practical insights for navigating the complexities of oligonucleotide therapy development. Schedule a meeting with our team: WuXi_TIDES@wuxiapptec.com Learn more: https://lnkd.in/g6AmChYd #WuXiTIDES #peptides #oligonucleotides #CRDMO
2 Comments
Like Comment
To view or add a comment, sign in
Taylor Wilson

Sales Representative at Product Partners
2mo
Report this post
The Future of Exosome Based Therapeutics: Key Clinical Updates ZEO ScientifiX™ invites you to a LIVE Webinar on The Future of Exosome Based Therapeutics with Dr. George Shapiro, MD https://lnkd.in/g5pnyr42
Like Comment
To view or add a comment, sign in
SRI Biosciences

985 followers
3mo
Report this post
We're at #PEGSummit this week! Our scientists Shelby Knoche and Michael J McGuire will be presenting on SRI's targeted drug delivery technologies. If you're not at the conference, you can learn more about our platform, called FOX Three, for cell-selective intracellular delivery of macromolecular therapeutics here: https://lnkd.in/g65HJvt4 #drugdelivery #precisionmedicine
Like Comment
To view or add a comment, sign in

14,447 followers

View Profile Follow

Repare Therapeutics’ Post

More Relevant Posts

Explore topics